368 related articles for article (PubMed ID: 28993028)
1. The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.
Halliday GC; Junckerstorff RC; Bentel JM; Miles A; Jones DTW; Hovestadt V; Capper D; Endersby R; Cole CH; van Hagen T; Gottardo NG
J Clin Neurosci; 2018 Jan; 47():163-167. PubMed ID: 28993028
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathology of tumors of the central nervous system.
Kristensen BW; Priesterbach-Ackley LP; Petersen JK; Wesseling P
Ann Oncol; 2019 Aug; 30(8):1265-1278. PubMed ID: 31124566
[TBL] [Abstract][Full Text] [Related]
3. C19MC amplification and expression of Lin28A and Olig2 in the classification of embryonal tumors of the central nervous system: A 14-year retrospective study from a tertiary care center.
Nambirajan A; Gurung N; Suri V; Sarkar C; Kumar A; Singh M; Sharma MC
Childs Nerv Syst; 2021 Apr; 37(4):1067-1075. PubMed ID: 33236184
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and molecular characterization of a case classified by DNA‑methylation profiling as "CNS embryonal tumor with BRD4-LEUTX fusion".
Lebrun L; Allard-Demoustiez S; Gilis N; Van Campenhout C; Rodesch M; Roman C; Calò P; Lolli V; David P; Fricx C; De Witte O; Escande F; Maurage CA; Salmon I
Acta Neuropathol Commun; 2023 Mar; 11(1):46. PubMed ID: 36934287
[TBL] [Abstract][Full Text] [Related]
5. Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up.
Schepke E; Löfgren M; Pietsch T; Kling T; Nordborg C; Olsson Bontell T; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sabel M; Lannering B; Carén H
Clin Epigenetics; 2023 Mar; 15(1):40. PubMed ID: 36895035
[TBL] [Abstract][Full Text] [Related]
6. Embryonal tumors in the WHO CNS5 classification: A Review.
Gianno F; Miele E; Antonelli M; Giangaspero F
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
[TBL] [Abstract][Full Text] [Related]
7. LIN28A, a sensitive immunohistochemical marker for Embryonal Tumor with Multilayered Rosettes (ETMR), is also positive in a subset of Atypical Teratoid/Rhabdoid Tumor (AT/RT).
Rao S; Rajeswarie RT; Chickabasaviah Yasha T; Nandeesh BN; Arivazhagan A; Santosh V
Childs Nerv Syst; 2017 Nov; 33(11):1953-1959. PubMed ID: 28744687
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.
von Hoff K; Haberler C; Schmitt-Hoffner F; Schepke E; de Rojas T; Jacobs S; Zapotocky M; Sumerauer D; Perek-Polnik M; Dufour C; van Vuurden D; Slavc I; Gojo J; Pickles JC; Gerber NU; Massimino M; Gil-da-Costa MJ; Garami M; Kumirova E; Sehested A; Scheie D; Cruz O; Moreno L; Cho J; Zeller B; Bovenschen N; Grotzer M; Alderete D; Snuderl M; Zheludkova O; Golanov A; Okonechnikov K; Mynarek M; Juhnke BO; Rutkowski S; Schüller U; Pizer B; von Zezschwitz B; Kwiecien R; Wechsung M; Konietschke F; Hwang EI; Sturm D; Pfister SM; von Deimling A; Rushing EJ; Ryzhova M; Hauser P; Łastowska M; Wesseling P; Giangaspero F; Hawkins C; Figarella-Branger D; Eberhart C; Burger P; Gessi M; Korshunov A; Jacques TS; Capper D; Pietsch T; Kool M
Neuro Oncol; 2021 Sep; 23(9):1597-1611. PubMed ID: 34077956
[TBL] [Abstract][Full Text] [Related]
9. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
Liu APY; Dhanda SK; Lin T; Sioson E; Vasilyeva A; Gudenas B; Tatevossian RG; Jia S; Neale G; Bowers DC; Hassall T; Partap S; Crawford JR; Chintagumpala M; Bouffet E; McCowage G; Broniscer A; Qaddoumi I; Armstrong G; Wright KD; Upadhyaya SA; Vinitsky A; Tinkle CL; Lucas J; Chiang J; Indelicato DJ; Sanders R; Klimo P; Boop FA; Merchant TE; Ellison DW; Northcott PA; Orr BA; Zhou X; Onar-Thomas A; Gajjar A; Robinson GW
Acta Neuropathol; 2022 Oct; 144(4):733-746. PubMed ID: 35982322
[TBL] [Abstract][Full Text] [Related]
10. Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity.
Korshunov A; Sturm D; Ryzhova M; Hovestadt V; Gessi M; Jones DT; Remke M; Northcott P; Perry A; Picard D; Rosenblum M; Antonelli M; Aronica E; Schüller U; Hasselblatt M; Woehrer A; Zheludkova O; Kumirova E; Puget S; Taylor MD; Giangaspero F; Peter Collins V; von Deimling A; Lichter P; Huang A; Pietsch T; Pfister SM; Kool M
Acta Neuropathol; 2014 Aug; 128(2):279-89. PubMed ID: 24337497
[TBL] [Abstract][Full Text] [Related]
11. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnostics of CNS embryonal tumors.
Pfister SM; Korshunov A; Kool M; Hasselblatt M; Eberhart C; Taylor MD
Acta Neuropathol; 2010 Nov; 120(5):553-66. PubMed ID: 20882288
[TBL] [Abstract][Full Text] [Related]
13. MEK Inhibitors Reverse Growth of Embryonal Brain Tumors Derived from Oligoneural Precursor Cells.
Modzelewska K; Boer EF; Mosbruger TL; Picard D; Anderson D; Miles RR; Kroll M; Oslund W; Pysher TJ; Schiffman JD; Jensen R; Jette CA; Huang A; Stewart RA
Cell Rep; 2016 Oct; 17(5):1255-1264. PubMed ID: 27783941
[TBL] [Abstract][Full Text] [Related]
14. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care.
Karimi S; Zuccato JA; Mamatjan Y; Mansouri S; Suppiah S; Nassiri F; Diamandis P; Munoz DG; Aldape KD; Zadeh G
Clin Epigenetics; 2019 Dec; 11(1):185. PubMed ID: 31806041
[TBL] [Abstract][Full Text] [Related]
15. Gliomatosis cerebri: no evidence for a separate brain tumor entity.
Herrlinger U; Jones DTW; Glas M; Hattingen E; Gramatzki D; Stuplich M; Felsberg J; Bähr O; Gielen GH; Simon M; Wiewrodt D; Schabet M; Hovestadt V; Capper D; Steinbach JP; von Deimling A; Lichter P; Pfister SM; Weller M; Reifenberger G
Acta Neuropathol; 2016 Feb; 131(2):309-319. PubMed ID: 26493382
[TBL] [Abstract][Full Text] [Related]
16. Germ cell tumors with neuroglial differentiation do not show molecular features akin to their central nervous system counterpart: experience from extra-gynecological sites.
Chatterjee D; Gude G; Samujh R; Mete UK; Radotra B
Virchows Arch; 2022 Aug; 481(2):213-221. PubMed ID: 35678876
[TBL] [Abstract][Full Text] [Related]
17. Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion.
Andreiuolo F; Ferrone CK; Rajan S; Perry A; Guney E; Cham E; Giannini C; Toland A; Willard N; de Souza AS; Dazelle K; Chung HJ; Singh O; Conway K; Coley N; Dampier C; Abdullaev Z; Pratt D; Cimino PJ; Quezado M; Aldape K
Acta Neuropathol Commun; 2024 Mar; 12(1):42. PubMed ID: 38500181
[TBL] [Abstract][Full Text] [Related]
18. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
[TBL] [Abstract][Full Text] [Related]
19. Embryonal and non-meningothelial mesenchymal tumors of the central nervous system - Advances in diagnosis and prognostication.
Meredith DM; Alexandrescu S
Brain Pathol; 2022 Jul; 32(4):e13059. PubMed ID: 35266242
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
